4.4 Review

Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review

期刊

CLINICAL RHEUMATOLOGY
卷 40, 期 3, 页码 1141-1145

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s10067-020-05285-z

关键词

Autoimmune disease; Neutrophilic dermatoses; Pyoderma gangrenosum; Rheumatic disease; Scleroderma; Systemic sclerosis; T cell

向作者/读者索取更多资源

Pyoderma gangrenosum is a skin disease characterized by painful ulcers that can lead to permanent disfigurement if not appropriately treated. It is often observed in various autoimmune disorders but rarely associated with systemic sclerosis. Treatment with intravenous methylprednisolone and topical clobetasol can lead to complete resolution of the ulcerated lesions.
Pyoderma gangrenosum (PG) is a skin disease characterized by painful ulcers that, when not appropriately treated, can lead to permanent disfigurement. Pyoderma gangrenosum has been observed in a multitude of autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease (IBD), and sarcoidosis (Feld et al. J Rheumatol. 39(1):197,2012; Herrero et al. J Rheumatol. 36:7:1557-1558,2009). It is rarely associated with autoimmune disorders such as systemic sclerosis. We report a case of a patient with known limited cutaneous systemic sclerosis who developed an ulcerated lesion on the 2nd digit of the left hand. The lesion was initially thought to be cellulitis and the patient underwent superficial wound debridement. Postoperatively, the patient's lesions worsened. The patient was treated with intravenous (IV) methylprednisolone and 0.05% topical clobetasol due to high suspicion for PG with complete resolution of ulcerated lesions and minimal scarring.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据